These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1131 related articles for article (PubMed ID: 12669968)

  • 1. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
    Jiang G; Qiu W; DeLuca PP
    Pharm Res; 2003 Mar; 20(3):452-9. PubMed ID: 12669968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
    Woo BH; Jiang G; Jo YW; DeLuca PP
    Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM; Kim SW
    Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres.
    Rosa GD; Iommelli R; La Rotonda MI; Miro A; Quaglia F
    J Control Release; 2000 Nov; 69(2):283-95. PubMed ID: 11064135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
    J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone.
    Capan Y; Jiang G; Giovagnoli S; Na KH; DeLuca PP
    AAPS PharmSciTech; 2003; 4(2):E28. PubMed ID: 12916910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
    Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
    Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres.
    Liu B; Dong Q; Wang M; Shi L; Wu Y; Yu X; Shi Y; Shan Y; Jiang C; Zhang X; Gu T; Chen Y; Kong W
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1474-9. PubMed ID: 21048339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach to prepare insulin-loaded poly(lactic-co-glycolic acid) microcapsules and the protein stability study.
    Emami J; Hamishehkar H; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    J Pharm Sci; 2009 May; 98(5):1712-31. PubMed ID: 18855911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres.
    Shao PG; Bailey LC
    Pharm Dev Technol; 1999; 4(4):633-42. PubMed ID: 10578518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying.
    Quaglia F; De Rosa G; Granata E; Ungaro F; Fattal E; Immacolata La Rotonda M
    J Control Release; 2003 Jan; 86(2-3):267-78. PubMed ID: 12526823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of PLGA hydrophilia on the drug release and the hypoglucemic activity of different insulin-loaded PLGA microspheres.
    Presmanes C; de Miguel L; Espada R; Alvarez C; Morales E; Torrado JJ
    J Microencapsul; 2011; 28(8):791-8. PubMed ID: 21967461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
    J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres.
    Uchida T; Yagi A; Oda Y; Nakada Y; Goto S
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):235-6. PubMed ID: 8582042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
    Sheshala R; Peh KK; Darwis Y
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.